Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Mar 6, 2024; 12(7): 1243-1250
Published online Mar 6, 2024. doi: 10.12998/wjcc.v12.i7.1243
Table 2 Primary and secondary outcomes, n (%)
Parameters
S-PCNL (n = 186)
M-PCNL (n = 159)
P value
The stone free rate (SFR)
    1 month (yes)186 (100)159 (100)-
    3 months (yes)164 (88.17)138 (86.79)0.699
    6 months (yes) 126 (67.74)124 (77.98)0.033
Complication
    Pelvicalyceal system perforation or persistent leakage of urine10 (5.37)13 (8.17)0.242
    Transfusion needed because of bleeding7 (3.76)11 (6.91)0.189
Hydrothorax4 (2.15)11 (6.91)0.030
    Urosepsis4 (2.15)5 (3.14)0.563
    Fever26 (14.05)29 (18.23)0.281
    Renal hemorrhage5 (2.70)4 (3.77)0.920
    Urinary damage8 (4.32)7 (6.28)0.963
Postoperative infection 3 (1.62)11 (3.77)0.012